InvestorsHub Logo
Followers 467
Posts 26931
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 201

Thursday, 08/26/2010 5:41:50 PM

Thursday, August 26, 2010 5:41:50 PM

Post# of 392
4:01PM Vanda Pharma Initiates Phase III clinical study aimed at resetting the body clock (VNDA) 6.36 +0.01 : Co announced it has initiated a Phase III clinical trial to evaluate tasimelteon in patients with non-24-hour sleep wake disorder, a condition experienced primarily by totally blind individuals that results in abnormal night sleep patterns and chronic daytime sleepiness.


surf's up......crikey



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VNDA News